Stoke Therapeutics STOK
NASDAQ STOK
$26.75 +0.14 (+0.53%)
As of: Oct 21, 2026 · 11:41 AM EDT

Stoke Therapeutics (STOK) Preferred Shares (2018)

Updated

Stoke Therapeutics (STOK) reported Preferred Shares of $260.69 million for Q4 2018.

Analysis

Stoke Therapeutics (STOK) Preferred Shares (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn -
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn -
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -
10 Stoke Therapeutics 1.76 Bn 593.99 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 260.69 Mn
API Access

Stoke Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=STOK&period=max&api_key=YOUR_API_KEY